Autologous CD19-targeted CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CD19-targeted CAR-T cell therapy, covering 2025-05-23 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 [Phase 1]